Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review
Authors:
Open Access
- 5 January 2024
- journal article
- review article
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 18
Abstract
Colorectal cancer is the third most prevalent cancer worldwide, and its treatment has been a demanding clinical problem. Beyond traditional surgical therapy and chemotherapy, newly revealed molecular mechanisms diversify therapeutic approaches for colorectal cancer. However, the selection of personalized treatment among multiple treatment options has become another challenge in the era of precision medicine. Artificial intelligence has recently been increasingly investigated in the treatment of colorectal cancer. This narrative review mainly discusses the applications of artificial intelligence in the treatment of colorectal cancer patients. A comprehensive literature search was conducted in MEDLINE, EMBASE, and Web of Science to identify relevant papers, resulting in 49 articles being included. The results showed that, based on different categories of data, artificial intelligence can predict treatment outcomes and essential guidance information of traditional and novel therapies, thus enabling individualized treatment strategy selection for colorectal cancer patients. Some frequently implemented machine learning algorithms and deep learning frameworks have also been employed for long-term prognosis prediction in patients with colorectal cancer. Overall, artificial intelligence shows encouraging results in treatment strategy selection and prognosis evaluation for colorectal cancer patients.Keywords
This publication has 109 references indexed in Scilit:
- Artificial Intelligence, Big Data, and CancerJAMA Oncology, 2015
- Deep learningNature, 2015
- Support Vector Feature Selection for Early Detection of Anastomosis Leakage From Bag-of-Words in Electronic Health RecordsIEEE Journal of Biomedical and Health Informatics, 2014
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trialThe Lancet Oncology, 2014
- Personalizing Therapy for Colorectal CancerClinical Gastroenterology and Hepatology, 2014
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataThe Lancet Oncology, 2010
- Microsatellite instability in colorectal cancer—the stable evidenceNature Reviews Clinical Oncology, 2010
- Population-Based Analyses of Lymph Node Metastases in Colorectal CancerClinical Gastroenterology and Hepatology, 2006
- Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined populationBritish Journal of Surgery, 2006
- Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2003